|Bid||249.01 x 1100|
|Ask||263.99 x 800|
|Day's Range||247.64 - 264.99|
|52 Week Range||168.65 - 296.25|
|Beta (5Y Monthly)||0.76|
|PE Ratio (TTM)||51.48|
|Earnings Date||Apr 28, 2020 - May 03, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||272.40|
A German shepherd pet dog in Hong Kong has repeatedly tested positive for the Covid-19 virus after its owner was confirmed as being infected, authorities said.
The Hong Kong pet dog that was tested for coronavirus has died two days after being released from a government quarantine having been declared virus-free.
HealthEquity's (HQY) fiscal fourth-quarter earnings benefit from higher revenues and solid performing Service, Custodial and Interchange segments.
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced that the company has seen no positive results in pets to date of SARS-CoV-2, the coronavirus strain responsible for the coronavirus disease 2019 (COVID-19) respiratory outbreak in humans. IDEXX evaluated thousands of canine and feline specimens during validation of a new veterinary test system for the COVID-19 virus. The specimens used for test development and validation were obtained from specimens submitted to IDEXX Reference Laboratories for PCR testing.
As a result of regular market fluctuations, several growth stocks have become ultra-cheap at present, some of which have strong growth potential.
Allscripts (MDRX) fourth-quarter results gain from higher revenues along with growth in bookings. Contraction in both gross and operating margins remains a woe.